Top 15 Medical Angel Investors in Italy (October 2026)

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
• Reasoned Art — Reasoned Art is the Italian gallery dedicated to CryptoArt. it selects the best digital artists worldwide, curates physical and virtual exhibitions, and certifies the authenticity of works allowing their sale through NFT.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
• Bettyvision —

Portfolio highlights

• Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.

Portfolio highlights

• Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.

Portfolio highlights

• Tot — Tot is a business banking platform for SMEs.
• Private Labs — Our mission is to assist investors and financial institutions in creating their Private Fund Book-of-Record by extracting data from documents supplied by General Partners, automated with modern AI technology, data enrichment algorithms and with human oversight and control, to ensure high-quality Private Fund data for the organisation.
• Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.

Portfolio highlights

• Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.

Portfolio highlights

• Arcadia Earth — WHAT IS IT? Arcadia Earth is a large scale multi-sensorial journey through underwater worlds, fantasy lands, and inspirational art installations.
• CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.

Portfolio highlights

• EBAMed — EBAMed builds CardioKit: live ultrasound that follows the heart during radiotherapy and gates the beam, whether the heart is the target or the organ to protect.
• Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
• CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.

Portfolio highlights

• TENSIVE — Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to offer a natural breast reconstruction or augmentation.Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to offer a natural breast reconstruction or augmentation.

Portfolio highlights

• ChemiCare — Cutting-edge drugs for calcium-related diseases such as Tubular Aggregate Myopathies, Duchenne Muscular Dystrophy, and Acute Pancreatitis.
• Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.

Portfolio highlights

• I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Portfolio highlights

• Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
• Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
• Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation